Subscribe to our global insights

Stay ahead of the curve

Subscribe to our global reports and analyses to stay on top of international business trends. Receive curated insights such as Export Manager’s Index, Global Economic Outlook, Foreign Direct Investment updates, and selected reports for decision-makers in global business.

Global growth insights

The Compass brings together insights, trends, and opportunities from markets worldwide—helping you navigate complexity, identify growth potential, and make informed decisions. Designed for companies with international ambitions.

Ukraine business updates

Sign up for Business Sweden’s Ukraine newsletter to receive the latest insights, key developments, and business events in the Ukrainian market—helping your company stay informed, identify opportunities, and contribute to ongoing reconstruction efforts.

EGI-subhero-1200x700-v1.jpg

Global strategy starts here

Subscribe to Executive Global Insights for in-depth analysis of the trends, risks, and opportunities defining cross-border trade. Produced by our experts in more than 40 markets, with a clear industry-driven perspective.

Opportunities for Swedish companies in offshore wind

Offshore wind plays a central role in the global energy transition, offering significant potential for decarbonisation while strengthening energy security. As deployment accelerates across Europe, Northeast Asia and North America, the offshore wind value chain is expanding and creating new opportunities for suppliers.

Dark clouds over the world economy

The global economy proved resilient in 2025, growing by 3 per cent despite geopolitical and trade policy turmoil. But the outlook is uncertain – a prolonged war in the Middle East would trigger a major setback. In the first edition of Global Economic Outlook this year, Business Sweden presents two scenarios for the path ahead.

Staying competitive in a rapidly evolving ATMP market

Advanced Therapy Medicinal Products (ATMPs) are redefining modern medicine by addressing the root causes of disease through gene therapy, cell therapy, and tissue engineering. Once considered experimental, these treatments are now delivering potentially curative outcomes across oncology, rare diseases and neurological disorders.